(INNS)
ZIRKONIUM-(89ZR) GIRENTUXIMAB SENVEDOXAM(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS CARBONIC ANHYDRASE 9 (CA9, CARBONIC ANHYDRASE IX, CAIX, MN, G250)], CHIMERIC MONOCLONAL ANTIBODY; CONJUGATED ON L-LYSINE RESIDUES TO ZIRCONIUM (^89ZR) RADIOLABELLED SENVEDOXAM, WITH AN AVERAGE RATIO OF 1 TO 1.5; ... PROPOSED INN: LIST 130, RECOMMENDED INN: LIST 92(WHO)
ZIRCONIUM (89ZR) GIRENTUXIMABUM SENVEDOXAMUM(INN)